About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Portland | 9,759 Studies Near You

Clinical TrialsPortland

Clinical Trials in Portland

Discover 9,759 clinical trials near Portland, Oregon. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 5881-5900 of 9,759 trials

CompletedS0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast CancerRATIONALE: Cholecalciferol may prevent breast cancer in premenopausal women.NCT01097278·Anniston, Alabama and 359 others

Find Trials by Condition in Portland

Breast Cancerin Portland Lung Cancerin Portland Prostate Cancerin Portland Colorectal Cancerin Portland Melanomain Portland Leukemiain Portland Lymphomain Portland Pancreatic Cancerin Portland Ovarian Cancerin Portland Brain Cancerin Portland Diabetes

Data from ClinicalTrials.govTerms

CompletedStudy of the Safety and Neuroprotective Capacity of Scp776 in Acute Ischemic StrokeA Randomized, Placebo-Controlled, Double-Blind, Multicenter Study of the Safety and Neuroprotective Capacity of Scp776 in Subjects Undergoing Endovascular Thrombectomy for Acute…NCT05585606·Scottsdale, Arizona and 21 others

CompletedMemantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain MetastasesThis randomized phase III trial compares memantine hydrochloride and whole-brain radiotherapy with or without hippocampal avoidance in reducing neurocognitive decline in patients…NCT02360215·Tuscaloosa, Alabama and 219 others

CompletedImmunogenicity and Safety of Tetravalent Dengue Vaccine Candidate (TDV) in Flavivirus-Naïve and Dengue-Immune AdultsThe purpose of this study is to assess the neutralizing antibody response against each dengue serotype post-vaccination.NCT03746015·Peoria, Illinois and 1 other

CompletedMeasuring Preferences for Childbirth After CesareanThe objective of this proposed 18-month exploratory research study is to help pregnant women weigh risks and benefits in a childbirth decision using the Preferences-Assessment…NCT00267735·Portland, Oregon

CompletedEvaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure.The purpose of this study is to evaluate the efficacy of a 24-hour infusion of levosimendan compared with placebo in the treatment of decompensated chronic heart failure.NCT00048425·Birmingham, Alabama and 165 others

CompletedAO-176 in Multiple Solid Tumor MalignanciesThis is a first-in-human, Phase 1/2 multi-center, open-label, dose escalation and expansion study of AO-176 which will evaluate the safety, tolerability, pharmacokinetics (PK)…NCT03834948·Los Angeles, California and 9 others

RecruitingA Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple MyelomaThe goal of this clinical trial is to evaluate the safety, tolerability, and recommended Phase 2 Dose (RP2D) of KLN-1010 in patients with relapsed or refractory multiple myeloma.NCT07075185·Duarte, California and 10 others

CompletedS1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary AmyloidosisThis phase II trial studies how well isatuximab works in treating patients with primary amyloidosis that has come back or does not respond to treatment.NCT03499808·Anchorage, Alaska and 344 others

CompletedRandomized Evaluation of Strategic Intervention in Multidrug Resistant Patients With Tipranavir (RESIST)Demonstrate the safety and efficacy of Tipranavir/Ritonavir versus an active treatment regimen in highly treatment experienced Human Immunodeficiency virus 1(HIV-1) infected…NCT00054717·Phoenix, Arizona and 116 others

Active not recruitingA Study of BR Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated MCLThis study is evaluating the efficacy of acalabrutinib in combination with bendamustine and rituximab (BR) compared with placebo plus BR in subjects with previously untreated…NCT02972840·Tucson, Arizona and 227 others

CompletedThe Effects of Emollient Therapy on the Skin BarrierThe goal of this study is to better understand what effect emollients (moisturizers) have on the skin in young children and adults.NCT01291940·Portland, Oregon

CompletedOutcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With HypertriglyceridemiaThe study is a randomized, double-blind, placebo-controlled (corn oil), parallel group design that will enroll approximately 13,000 patients with hypertriglyceridemia and low HDL…NCT02104817·Birmingham, Alabama and 683 others

Active not recruitingA Global Study to Assess the Effects of Durvalumab With Oleclumab or Durvalumab With Monalizumab Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung CancerThis is a Phase III, randomised, double-blind, multicentre, international study assessing the efficacy and safety of durvalumab (MEDI4736) in combination with oleclumab (MEDI9447)…NCT05221840·San Diego, California and 201 others

CompletedSafety and Efficacy of Bexagliflozin Compared to Placebo as Add-on Therapy to Metformin in Type 2 Diabetes SubjectsThe purpose of this study is to investigate the effect of bexagliflozin compared to placebo as an add-on therapy to metformin in lowering hemoglobin A1c (HbA1c) levels in subjects…NCT03259789·Birmingham, Alabama and 42 others

TerminatedA Study of TAS1440 With ATRA in Subjects With r/r AMLThis is a multicenter, 2-part, Phase 1 study to assess the safety, pharmacokinetics, pharmacodynamics, and preliminary clinical activity of TAS1440 administered as a single agent…NCT04282668·Tucson, Arizona and 7 others

Active not recruitingCOMbination Regimens in MM Post AHCT to elimiNate MRD Utilizing IbERdomideSimilar to the paradigm established in other hematologic malignancies that are considered curable, the achievement of MRD(-) status is necessary for long term disease control in…NCT05434689·Birmingham, Alabama and 3 others

CompletedA Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)This open-label, randomized study will assess the efficacy and safety of obinutuzumab (RO5072759) in combination with chemotherapy compared to rituximab (MabThera/Rituxan) with…NCT01332968·Springdale, Arkansas and 182 others

RecruitingStudy to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young ChildrenThis is a two-part, multi-center, prospective longitudinal, exploratory study of highly effective cystic fibrosis transmembrane conductance regulator (CFTR) modulators and their…NCT04509050·Birmingham, Alabama and 34 others

CompletedTopical CP-690,550 For Chronic Plaque PsoriasisStudy will test effectiveness of an experimental drug applied once or twice daily to two psoriasis plaques. Requires 1 clinic visit each week for 5 weeks.NCT00678561·Irvine, California and 19 others

PreviousPage 295 of 488Next

in Portland

Heart Diseasein Portland